pneumococcal vaccine ( Hanavax/Yisheng Biopharma/University of Alabama/University of Kyoto)

N/A

Report date: 2025/01/26 15:34:00

Base Information

Drug Namepneumococcal vaccine ( Hanavax/Yisheng Biopharma/University of Alabama/University of Kyoto)
Drug Alias Nameprotein recombinant pneumococcal vaccine (Hanavax/Yisheng Biopharma/University of Alabama/University of Kyoto)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis MediaSepsisPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Tokyo
China Registration ClassN/A

Develop Information

Active CompaniesHanavax IncLakeShore Biopharma Co LtdKyoto University +[5] 
Inactive CompaniesUniversity Of Tokyo
Active IndicationsOtitis MediaSepsisPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A